DOCSLIB.ORG

Sigma Biochemical Condensed Phase

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Sigma Biochemical Condensed Phase Library Listing – 10,411 spectra This library provides a comprehensive spectral collection of the most common chemicals found in the Sigma Biochemicals and Reagents catalog. It includes an extensive combination of spectra of interest to the biochemical field. The Sigma Biochemical Condensed Phase Library contains 10,411 spectra acquired by Sigma-Aldrich Co. which were examined and processed at Thermo Fisher Scientific. These spectra represent a wide range of chemical classes of particular interest to those engaged in biochemical research or QC. The spectra include compound name, molecular formula, CAS (Chemical Abstract Service) registry number, and Sigma catalog number. Sigma Biochemical Condensed Phase Index Compound Name Index Compound Name 8951 (+)-1,2-O-Isopropylidene-sn-glycerol 8718 (+/-)-Homocitric acid lactone 7703 (+)-10-Camphorsulfonic acid 4739 (+/-)-Isoproterenol .HCl 10051 (+)-2,2,2-Trifluoro-1-(9-anthryl)ethanol 4738 (+/-)-Isoproterenol, hemisulfate salt 8016 (+)-2,3-Dibenzoyl-D-tartaric acid 5031 (+/-)-Methadone .HCl 8948 (+)-2,3-O-Isopropylidene-2,3- 9267 (+/-)-Methylsuccinic acid dihydroxy-1,4-bis- 9297 (+/-)-Miconazole, nitrate salt (diphenylphosphino)but 9361 (+/-)-Nipecotic acid 6164 (+)-2-Octanol 9618 (+/-)-Phenylpropanolamine .HCl 9110 (+)-6-Methoxy-a-methyl-2- 4923 (+/-)-Sulfinpyrazone naphthaleneacetic acid 10404 (+/-)-Taxifolin 7271 (+)-Amethopterin 4469 (+/-)-Tetrahydropapaveroline .HBr 4368 (+)-Bicuculline 4992 (+/-)-Verapamil, .HCl 7697 (+)-Camphor 9145 (+/-)-a-(Methylaminomethyl)benzyl 7729 (+)-Catechin .H2O alcohol 7868 (+)-Citramalic acid, Na salt 9146 (+/-)-a-(Methylaminomethyl)benzyl 4401 (+)-Ephedrine .HCl alcohol, benzoate salt 8932 (+)-Isomenthol 4777 (+/-)Metoprolol (+)tartrate 4742 (+)-Isoproterenol (+)-bitartrate 4405 (-) Ephedrine nitrate 9009 (+)-Longifolene 4987 (-) Usnic acid 5032 (+)-Methamphetamine .HCl 8400 (-)-1,4-Dithio-L-threitol 8022 (+)-N,N'-Dibenzyl-L-tartramide 10052 (-)-2,2,2-Trifluoro-1-(9-anthryl)ethanol 9350 (+)-Neomenthol 8403 (-)-2,3-Di-p-toluoyl-L-tartaric acid 9476 (+)-Noe-lactol dimer 8017 (-)-2,3-Dibenzoyl-L-tartaric acid 941 (+)-Octopinic acid 8947 (-)-2,3-O-Isopropylidene-2,3-dihydroxy- 9619 (+)-Phenylpropanolamine .HCl 1,4-bis-(diphenylphosphino)but 4395 (+)-Psi-ephedrine 8952 (-)-2,3-O-Isopropylidene-sn-glycerol 4397 (+)-Psi-ephedrine .HCl 6165 (-)-2-Octanol 4396 (+)-Psi-ephedrine hemisulfate 4391 (-)-3,4-Dihydroxy-norephedrine 9862 (+)-Tartaric acid dibutyl ester 474 (-)-Allo-cystathionine 9863 (+)-Tartaric acid diethyl ester 7272 (-)-Amethopterin 9865 (+)-Tartaric acid dimethyl ester 4540 (-)-Arterenol 4988 (+)-Usnic acid 4542 (-)-Arterenol .HCl 9132 (+)-a-Methoxy-a- 4541 (-)-Arterenol bitartrate (trifluoromethyl)phenylacetic acid 4369 (-)-Bicuculline methobromide 9670 (+)-a-Pinene 7575 (-)-Borneol 7650 (+)-p-Bromotetramisole oxalate 7576 (-)-Bornyl acetate 4413 (+)Glaucine 7867 (-)-Citramalic acid, Na salt 6146 (+/-) Linalool 4386 (-)-Cotinine 8086 (+/-)-1,2:3,4-Diepoxybutane 4404 (-)-Ephedrine .HCl 8034 (+/-)-2,3-Dibromopropionitrile 4402 (-)-Ephedrine anhydrous 8480 (+/-)-2-Ethylhexylamine 4403 (-)-Ephedrine hemi-sulfate 6163 (+/-)-2-Octanol 8418 (-)-Epicatechin 6162 (+/-)-2-Octanol 4672 (-)-Epinephrine 4887 (+/-)-3-Quinuclidinol 4673 (-)-Epinephrine (+)-bitartrate 9780 (+/-)-3-Quinuclidinol benzoate 4740 (-)-Isoproterenol 7273 (+/-)-Amethopterin 4741 (-)-Isoproterenol (+)-bitartrate 4538 (+/-)-Arterenol 9063 (-)-Menthyl chloride 4539 (+/-)-Arterenol .HCl 9064 (-)-Menthyloxyacetic acid 7493 (+/-)-Benzoin 8023 (-)-N,N'-Dibenzyl-D-tartramide 7698 (+/-)-Camphor 9477 (-)-Noe-lactol dimer 7730 (+/-)-Catechin; 2-(3,4- 4440 (-)-Norpseudoephedrine .HCl Dihydroxyphenyl)-3,4-dihydro-2H-1- 4398 (-)-Psi ephedrine benzopyran-3 4399 (-)-Psi ephedrine .HCl 7866 (+/-)-Citramalic acid, Na salt 4446 (-)-Quinic acid 4383 (+/-)-Coniine 4459 (-)-Scopolamine .HBr 473 (+/-)-Cystathionine 4458 (-)-Scopolamine N-butylbromide 4400 (+/-)-Ephedrine .HCl 4457 (-)-Scopolamine aminoxide .HBr 2629 (+/-)-Epi-inosose-2 4460 (-)-Scopolamine methyl bromide 4671 (+/-)-Epinephrine 4461 (-)-Scopolamine methyl nitrate 4674 (+/-)-Epinephrine methyl ether .HCl 9816 (-)-Shikimic acid (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 1 of 104 Sigma Biochemical Condensed Phase Index Compound Name Index Compound Name 4463 (-)-Sparteine 8151 (E)-d3-Dihydromuconic acid 9820 (-)-Sparteine, sulfate salt 8373 (E)-p,p'-Diphenylstilbene 9864 (-)-Tartaric acid diethyl ester 9307 (E,E)-Muconic acid 9133 (-)-a-Methoxy-a- 9113 (Methoxymethyl)triphenylphosphonium (trifluoromethyl)phenylacetic acid chloride 7651 (-)-p-Bromotetramisole oxalate 7555 (R)-(+)-1,1'-Bi-2-naphthol 4393 (-)Eburnamonine 5177 (R)-(+)-2-Chloropropionic acid methyl 9062 (-)Menthol ester 7702 (1R)-(-)-Camphoroquinone 8293 (R)-(+)-N,N-Dimethyl-1- 4435 (1R,2S)-(-)-N-Methylephedrine phenethylamine 10024 (2,2,2-Trichloro-1- 9338 (R)-(+)-a-(1-Naphthyl)ethylamine hydroxyethyl)phosphonic acid dimethyl 7557 (R)-(-)-1,1'-Binaphthyl-2,2'-diyl ester hydrogen phosphate 7617 (2-Bromoethyl)trimethylammonium 6113 (R)-(-)-1,3-Butanediol bromide 6154 (R)-(-)-2-Methyl-2,4-pentanediol 6174 (2R,4R)-(-)-Pentanediol 8806 (R)-(-)-3-Hydroxy-2-methylpropionic 8237 (2S,3R)-(+)-4-Dimethylamino-1,2- acid methyl ester diphenyl-3-methyl-2-butanol 9201 (R)-(-)-Methyl 3-hydroxybutyrate 7267 (2S,3S)-(+)-2-Allyl-3-hydroxy-2- 9158 (R,R)-(+)-N,N'-Bis(a- methylcyclopentanone methylbenzyl)sulfamide 6175 (2S,4S)-(+)-Petanediol 6116 (R,R)-(-)-2,3-Butanediol 7726 (3-Carboxypropyl)trimethylammonium 7558 (S)-(+)-1,1'-Binaphthyl-2,2'-diyl chloride hydrogen phosphate 7719 (4-Carboxybutyl)triphenylphosphonium 6181 (S)-(+)-1,2-Propandiol bromide 6114 (S)-(+)-1,3-Butanediol 7760 (4R,5R)-(+)-2-Chloro-4,5-dimethyl- 9111 (S)-(+)-2-(Methoxymethyl)pyrrolidine 1,3,2-dioxaphosphole 9161 (S)-(+)-2-Methylbutyric acid 7320 (4S,5S)-(+)-5-Amino-2,2-dimethyl-4- 8807 (S)-(+)-3-Hydroxy-2-methylpropionic phenyl-1,3-dioxane acid methyl ester 7363 (Aminooxy)acetic acid .1/2 HCl 9202 (S)-(+)-Methyl 3-hydroxybutyrate 10049 (Bis(trifluoroacetoxy)iodo)benzene 7556 (S)-(-)-1,1'-Bi-2-naphthol 7712 (Carbomethoxymethyl)triphenylphospho 9112 (S)-(-)-2-(Methoxymethyl)-1- nium bromide pyrrolidinecarboxaldehyde 7723 (Carboxymethyl)trimethylammonium 6151 (S)-(-)-2-Methyl-1-butanol chloride hydrazide 9166 (S)-(-)-Methyl 2-chloropropionate 8377 (E)-1,4-Diphthalimido-2-methyl-2- 8294 (S)-(-)-N,N-Dimethyl-1-phenethylamine butene 9712 (S)-(-)-Propylene oxide 5543 (E)-11-Tetradecenyl acetate 9339 (S)-(-)-a-(1-Naphthyl)ethylamine 8052 (E)-2,4-Dichlorocinnamic acid 9159 (S,S)-(-)-N,N'-Bis(a- 5197 (E)-2-Dodecenedioic acid methylbenzyl)sulfamide 8709 (E)-2-Hexenal 5218 (Z)-11-Eicosenoic anhydride 9504 (E)-2-Octene 8691 (Z)-11-Hexadecenal 9130 (E)-4-Methoxystilbene 8693 (Z)-11-Hexadecenol 9505 (E)-4-Octene 5259 (Z)-11-Hexadecenyl acetate 7957 (E)-5-Decenol 9896 (Z)-11-Tetradecenol 5178 (E)-5-Decenyl acetate 5542 (Z)-11-Tetradecenyl acetate 5194 (E)-7,(Z)-9-Dodecadienyl acetate 9496 (Z)-13-Octadecenal 6127 (E)-8,(E)-10-Dodecadienol 9196 (Z)-14-Methyl-8-hexadecenal 5195 (E)-8,(E)-10-Dodecadienyl acetate 5260 (Z)-3-Hexenyl acetate 5083 (E)-Aconitic acid 6160 (Z)-3-Nonen-1-ol 4530 (E)-Anethole 5429 (Z)-3-Nonenyl acetate 7859 (E)-Cinnamic acid 5179 (Z)-5-Decenyl acetate 7861 (E)-Cinnamoyl chloride 5256 (Z)-7,(E)-11-Hexadecadienyl acetate 9830 (E)-Stilbene 5255 (Z)-7,(Z)-11-Hexadecadienyl acetate 9831 (E)-Stilbene oxide 6128 (Z)-7-Dodecen-1-ol 4929 (E)-Tamoxifen citrate 5198 (Z)-7-Dodecenyl acetate 5574 (E)-Vaccenic acid 9893 (Z)-7-Tetradecenal 5576 (E)-Vaccenic acid methyl ester 6187 (Z)-7-Tetradecenol 2373 (E)-Vaccenoyl coenzyme A 5541 (Z)-7-Tetradecenyl acetate 4573 (E)-b-Carotene type I 5199 (Z)-8-Dodecenyl acetate (c) 2007 Thermo Fisher Scientific Inc. All rights reserved. Page 2 of 104 Sigma Biochemical Condensed Phase Index Compound Name Index Compound Name 5538 (Z)-9,(E)-11-Tetradecadienyl acetate 10008 1,2,4-Triazole 5539 (Z)-9,(E)-12-Tetradecadienyl acetate 10078 1,2,4-Trimethoxybenzene 8668 (Z)-9-Heneicosene 10065 1,2,6-Trihydroxyhexane 8690 (Z)-9-Hexadecenal 7471 1,2-Benzanthracene 5258 (Z)-9-Hexadecenyl acetate 7365 1,2-Bis(2-aminophenoxy)ethane- 9895 (Z)-9-Tetradecenol N,N,N',N'-tetraacetic acid, tetrapotass 6188 (Z)-9-Tetradecenol 7766 1,2-Bis(2-chloroethoxy)ethane 10032 (Z)-9-Tricosene 5640 1,2-Di-O-hexadecyl-3-palamitoyl-rac- 5082 (Z)-Aconitic acid glycerol 7246 (Z)-Aconitic anhydride 5641 1,2-Di-O-hexadecyl-rac-glycerol 9829 (Z)-Stilbene 7967 1,2-Diacetylbenzene 5573 (Z)-Vaccenic acid 7979 1,2-Diaminocyclohexane-N,N,N',N'- 5575 (Z)-Vaccenic acid methyl ester tetraacetic acid, trans- 5577 (Z)-Vaccenoyl chloride 7990 1,2-Diaminopropane-N,N,N',N'- 2372 (Z)-Vaccenoyl coenzyme A tetraacetic acid 5578 (Z)-Vaccenyl acetate 8000 1,2-Dianilinoethane 6191 (Z)-Vaccenyl alcohol 8028 1,2-Dibromoethane 7715 1,1'-Carbonyldiimidazole 8055 1,2-Dichloroethane 8014 1,1'-Dibenzoylferrocene 8162 1,2-Dihydroxyethylene-bis-acrylamide 8103 1,1'-Diethyl-2,2'-cyanine iodide 5645 1,2-Dilauroyl-rac-glycerol 9956 1,1'-Thiocarbonyldiimidazole 8279 1,2-Dimethylimidazole 10091 1,1'-Trimethylene-bis-(4- 5649 1,2-Dimyristoyl-rac-glycerol formylpyridinium bromide) dioxime 5652 1,2-Dioleoyl-rac-glycerol 6140 1,1,1,3,3,3-Hexafluoro-2-propanol 5654 1,2-Dipalmitoyl-3-O-benzyl-rac- 10025 1,1,1-Trichloro-2-methyl-2-propanol glycerol 1/2 .H2O 5660 1,2-Dipalmitoyl-3-O-benzyl-sn-glycerol 8828 1,1,2,2-Tetrakis-(p- 5657 1,2-Dipalmitoyl-3-iodo-rac-3- hydroxyphenyl)ethane deoxyglycerol 10030 1,1,2-Trichlorotrifluoroethane
Recommended publications
  • Pest Management Strategic Plan for Strawberry Production in California

    Pest Management Strategic Plan for Strawberry Production in California

    PEST MANAGEMENT STRATEGIC PLAN FOR STRAWBERRY PRODUCTION IN CALIFORNIA 1 | Page TABLE OF CONTENTS INTRODUCTION ................................................................................................................................................... 5 Previous Pest Management Strategic Plan .............................................................................................. 5 Development of the New Plan .................................................................................................................... 5 STRAWBERRY MARKET SHARE AND VALUE.................................................................................................... 10 STRAWBERRY PRODUCTION OVERVIEW ........................................................................................................ 13 PEST MANAGEMENT FOR COMMERCIAL STRAWBERRY PLANTINGS ......................................................... 22 LAND PREPARATON THROUGH PLANTING ............................................................................................... 22 Activities Prior to Fumigation................................................................................................................. 22 Soil Fumigation ........................................................................................................................................ 22 Planting ..................................................................................................................................................... 25 Work Group Recommendations for
  • Aldrich FT-IR Collection Edition I Library

    Aldrich FT-IR Collection Edition I Library

    Aldrich FT-IR Collection Edition I Library Library Listing – 10,505 spectra This library is the original FT-IR spectral collection from Aldrich. It includes a wide variety of pure chemical compounds found in the Aldrich Handbook of Fine Chemicals. The Aldrich Collection of FT-IR Spectra Edition I library contains spectra of 10,505 pure compounds and is a subset of the Aldrich Collection of FT-IR Spectra Edition II library. All spectra were acquired by Sigma-Aldrich Co. and were processed by Thermo Fisher Scientific. Eight smaller Aldrich Material Specific Sub-Libraries are also available. Aldrich FT-IR Collection Edition I Index Compound Name Index Compound Name 3515 ((1R)-(ENDO,ANTI))-(+)-3- 928 (+)-LIMONENE OXIDE, 97%, BROMOCAMPHOR-8- SULFONIC MIXTURE OF CIS AND TRANS ACID, AMMONIUM SALT 209 (+)-LONGIFOLENE, 98+% 1708 ((1R)-ENDO)-(+)-3- 2283 (+)-MURAMIC ACID HYDRATE, BROMOCAMPHOR, 98% 98% 3516 ((1S)-(ENDO,ANTI))-(-)-3- 2966 (+)-N,N'- BROMOCAMPHOR-8- SULFONIC DIALLYLTARTARDIAMIDE, 99+% ACID, AMMONIUM SALT 2976 (+)-N-ACETYLMURAMIC ACID, 644 ((1S)-ENDO)-(-)-BORNEOL, 99% 97% 9587 (+)-11ALPHA-HYDROXY-17ALPHA- 965 (+)-NOE-LACTOL DIMER, 99+% METHYLTESTOSTERONE 5127 (+)-P-BROMOTETRAMISOLE 9590 (+)-11ALPHA- OXALATE, 99% HYDROXYPROGESTERONE, 95% 661 (+)-P-MENTH-1-EN-9-OL, 97%, 9588 (+)-17-METHYLTESTOSTERONE, MIXTURE OF ISOMERS 99% 730 (+)-PERSEITOL 8681 (+)-2'-DEOXYURIDINE, 99+% 7913 (+)-PILOCARPINE 7591 (+)-2,3-O-ISOPROPYLIDENE-2,3- HYDROCHLORIDE, 99% DIHYDROXY- 1,4- 5844 (+)-RUTIN HYDRATE, 95% BIS(DIPHENYLPHOSPHINO)BUT 9571 (+)-STIGMASTANOL
  • 8–21–09 Vol. 74 No. 161 Friday Aug. 21, 2009 Pages 42169–42572

    8–21–09 Vol. 74 No. 161 Friday Aug. 21, 2009 Pages 42169–42572

    8–21–09 Friday Vol. 74 No. 161 Aug. 21, 2009 Pages 42169–42572 VerDate Nov 24 2008 21:37 Aug 20, 2009 Jkt 217001 PO 00000 Frm 00001 Fmt 4710 Sfmt 4710 E:\FR\FM\21AUWS.LOC 21AUWS srobinson on DSKHWCL6B1PROD with MISCELLANEOUS II Federal Register / Vol. 74, No. 161 / Friday, August 21, 2009 The FEDERAL REGISTER (ISSN 0097–6326) is published daily, SUBSCRIPTIONS AND COPIES Monday through Friday, except official holidays, by the Office of the Federal Register, National Archives and Records PUBLIC Administration, Washington, DC 20408, under the Federal Register Subscriptions: Act (44 U.S.C. Ch. 15) and the regulations of the Administrative Paper or fiche 202–512–1800 Committee of the Federal Register (1 CFR Ch. I). The Assistance with public subscriptions 202–512–1806 Superintendent of Documents, U.S. Government Printing Office, Washington, DC 20402 is the exclusive distributor of the official General online information 202–512–1530; 1–888–293–6498 edition. Periodicals postage is paid at Washington, DC. Single copies/back copies: The FEDERAL REGISTER provides a uniform system for making Paper or fiche 202–512–1800 available to the public regulations and legal notices issued by Assistance with public single copies 1–866–512–1800 Federal agencies. These include Presidential proclamations and (Toll-Free) Executive Orders, Federal agency documents having general FEDERAL AGENCIES applicability and legal effect, documents required to be published by act of Congress, and other Federal agency documents of public Subscriptions: interest. Paper or fiche 202–741–6005 Documents are on file for public inspection in the Office of the Assistance with Federal agency subscriptions 202–741–6005 Federal Register the day before they are published, unless the issuing agency requests earlier filing.
  • Analytical Performance of an Immunoassay to Measure Proenkephalin ⁎ Leslie J

    Analytical Performance of an Immunoassay to Measure Proenkephalin ⁎ Leslie J

    Clinical Biochemistry xxx (xxxx) xxx–xxx Contents lists available at ScienceDirect Clinical Biochemistry journal homepage: www.elsevier.com/locate/clinbiochem Analytical performance of an immunoassay to measure proenkephalin ⁎ Leslie J. Donatoa, ,Jeffrey W. Meeusena, John C. Lieskea, Deborah Bergmannc, Andrea Sparwaßerc, Allan S. Jaffea,b a Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, United States b Division of Cardiology, Mayo Clinic, Rochester, MN 55905, United States c Sphingotec GmbH, Hennigsdorf, Germany ARTICLE INFO ABSTRACT Keywords: Background: Endogenous opioids, enkephalins, are known to increase with acute kidney injury. Since the mature Biomarkers pentapeptides are unstable, we evaluated the performance of an assay that measures proenkephalin 119–159 Proenkephalin (PENK), a stable peptide formed concomitantly with mature enkephalins. Enkephalin Methods: PENK assay performance was evaluated on two microtiterplate/chemiluminescence sandwich im- Pro-enkephalin munoassay formats that required 18 or 1 h incubation times. PENK concentration was measured in plasma from penKid healthy individuals to establish a reference interval and in patients with varied levels of kidney function and Assay validation comorbidities to assess the association with measured glomerular filtration rate (mGFR) using iothalamate clearance. Results: Assay performance characteristics in plasma were similar between the assay formats. Limit of quanti- tation was 26.0 pmol/L (CV = 20%) for the 1 h assay and 17.3 pmol/L (CV = 3%) for the 18 h assay. Measurable ranges were 26–1540 pmol/L (1 h assay) and 18–2300 pmol/L (18 h assay). PENK concentrations are stable in plasma stored ambient to 10 days, refrigerated to at least 15 days, and frozen to at least 90 days.
  • Sigma Fatty Acids, Glycerides, Oils and Waxes

    Sigma Fatty Acids, Glycerides, Oils and Waxes

    Sigma Fatty Acids, Glycerides, Oils and Waxes Library Listing – 766 spectra This library represents a material-specific subset of the larger Sigma Biochemical Condensed Phase Library relating to relating to fatty acids, glycerides, oils, and waxes found in the Sigma Biochemicals and Reagents catalog. Spectra acquired by Sigma-Aldrich Co. which were examined and processed at Thermo Fisher Scientific. The spectra include compound name, molecular formula, CAS (Chemical Abstract Service) registry number, and Sigma catalog number. Sigma Fatty Acids, Glycerides, Oils and Waxes Index Compound Name Index Compound Name 464 (E)-11-Tetradecenyl acetate 592 1-Monocapryloyl-rac-glycerol 118 (E)-2-Dodecenedioic acid 593 1-Monodecanoyl-rac-glycerol 99 (E)-5-Decenyl acetate 597 1-Monolauroyl-rac-glycerol 115 (E)-7,(Z)-9-Dodecadienyl acetate 599 1-Monolinolenoyl-rac-glycerol 116 (E)-8,(E)-10-Dodecadienyl acetate 600 1-Monolinoleoyl-rac-glycerol 4 (E)-Aconitic acid 601 1-Monomyristoyl-rac-glycerol 495 (E)-Vaccenic acid 598 1-Monooleoyl-rac-glycerol 497 (E)-Vaccenic acid methyl ester 602 1-Monopalmitoleoyl-rac-glycerol 98 (R)-(+)-2-Chloropropionic acid methyl 603 1-Monopalmitoyl-rac-glycerol ester 604 1-Monostearoyl-rac-glycerol; 1- 139 (Z)-11-Eicosenoic anhydride Glyceryl monosterate 180 (Z)-11-Hexadecenyl acetate 589 1-O-Hexadecyl-2,3-dipalmitoyl-rac- 463 (Z)-11-Tetradecenyl acetate glycerol 181 (Z)-3-Hexenyl acetate 588 1-O-Hexadecyl-rac-glycerol 350 (Z)-3-Nonenyl acetate 590 1-O-Hexadecyl-rac-glycerol 100 (Z)-5-Decenyl acetate 591 1-O-Hexadecyl-sn-glycerol
  • Activation of 5-HT2C (But Not 5-HT1A) Receptors in the Amygdala Enhances Fear-Induced Antinociception: Blockade with Local 5-HT2C Antagonist Or Systemic fluoxetine

    Activation of 5-HT2C (But Not 5-HT1A) Receptors in the Amygdala Enhances Fear-Induced Antinociception: Blockade with Local 5-HT2C Antagonist Or Systemic fluoxetine

    Neuropharmacology 135 (2018) 376e385 Contents lists available at ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm Activation of 5-HT2C (but not 5-HT1A) receptors in the amygdala enhances fear-induced antinociception: Blockade with local 5-HT2C antagonist or systemic fluoxetine Lígia Renata Rodrigues Tavares a, b, Daniela Baptista-de-Souza a, c, * Azair Canto-de-Souza a, b, c, d, a Psychobiology Group, Department of Psychology/CECH- Federal University of Sao~ Carlos-UFSCar, Sao~ Carlos, Sao~ Paulo, 13565-905, Brazil b Joint Graduate Program in Physiological Sciences UFSCar/UNESP, Sao~ Carlos, Sao~ Paulo, 13565-905, Brazil c Neuroscience and Behavioral Institute-IneC, Ribeirao~ Preto, Sao~ Paulo, 14040-901, Brazil d Program in Psychology UFSCar, Sao~ Carlos, Sao~ Paulo, 13565-905, Brazil article info abstract Article history: It is well-known that the exposure of rodents to threatening environments [e.g., the open arm of the Received 17 August 2017 elevated-plus maze (EPM)] elicits pain inhibition. Systemic and/or intracerebral [e.g., periaqueductal gray Received in revised form matter, amygdala) injections of antiaversive drugs [e.g., serotonin (5-HT) ligands, selective serotonin 5 March 2018 reuptake inhibitors (SSRIs)] have been used to change EPM-open arm confinement induced anti- Accepted 6 March 2018 nociception (OAA). Here, we investigated (i) the role of the 5-HT and 5-HT receptors located in the Available online 13 March 2018 1A 2C amygdaloid complex on OAA as well as (ii) the effects of systemic pretreatment with fluoxetine (an SSRI) on the effects of intra-amygdala injections of 8-OH-DPAT (a 5-HT1A agonist) or MK-212 (a 5-HT2C agonist) Keywords: fi Amygdala on nociception in mice con ned to the open arm or enclosed arm of the EPM.
  • Synthesis of Optically Pure Macroheterocycles with 2,6-Pyridinedicarboxylic and Adipic Acid Fragments from ∆3-Carene

    Synthesis of Optically Pure Macroheterocycles with 2,6-Pyridinedicarboxylic and Adipic Acid Fragments from ∆3-Carene

    Macrolides Paper Макролиды Статья DOI: 10.6060/mhc190660y Synthesis of Optically Pure Macroheterocycles with 2,6-Pyridinedicarboxylic and Adipic Acid Fragments from ∆3-Carene Marina P. Yakovleva,@ Kseniya S. Denisova, Galina R. Mingaleeva, Valentina A. Vydrina, and Gumer Yu. Ishmuratov Ufa Institute of Chemistry, Ufa Federal Research Center, Russian Academy of Sciences, 450054 Ufa, Russia @Corresponding author E-mail: [email protected] Based on the available natural monoterpene ∆3-carene we have developed the synthesis of four optically pure macroheterocycles with ester and dihydrazide fragments through the intermediate 1-((1S,3R)-3-(2-hydroxyethyl- 2,2-dimethylcyclopropyl)propan-2-one using its [2+1]-interaction with dichloranhydrides of adipic or 2,6-pyridinedicarboxylic acids and [1+1]-condensation of the obtained α,ω-diketodiesters with dihydrazides of adipic or 2,6-pyridinedicarboxylic acids. The structure of new compounds was confirmed by IR and NMR spectroscopy and mass spectrometry. Keywords: 3-Carenes, ozonolysis, sodium hypochlorite, macroheterocycles with ester and dihydrazide fragments, [2+1] and [1+1] condensations, synthesis. Синтез оптически чистых макрогетероциклов со сложноэфирными и дигидразидными фрагментами адипиновой и 2,6-пиридиндикарбоновой кислот из D3-карена М. П. Яковлева,@ К. С. Денисова, Г. Р. Мингалеева, В. А. Выдрина, Г. Ю. Ишмуратов Уфимский Институт химии – обособленное структурное подразделение Федерального бюджетного научного учреждения Уфимского федерального исследовательского центра Российской академии
  • Antitumor Activity of Actinonin in Vitro and in Vivo

    Antitumor Activity of Actinonin in Vitro and in Vivo

    Vol. 4, 171-176, January 1998 Clinical Cancer Research 171 Antitumor Activity of Actinonin in Vitro and in Vivo Yang Xu, Lawrence T. Lai, Janice L. Gabrilove, 8), mye!oid and monocytic cells, and most myeloblastic leuke- and David A. Scheinberg’ mias as well as on cells and tissues outside the hematopoietic system including fibroblasts, intestinal epithelium, renal tubular Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 epithelium, and synaptic membranes of the central nervous system (I ). APN occurs as a homodimer, and the molecule is a 150-kDa, transmembrane glycoprotein with an intracellular ABSTRACT amino terminus (1). F23, an antihuman CD13/APN mAb, is able Actinonin, an antibiotic and CD13/aminopeptidase N to completely block the active site of the enzyme (9). (APN) inhibitor, has been shown to be cytotoxic to tumor Bestatin, a CD 1 3/APN inhibitor, was examined in preclin- cell lines in vitro. We investigated the antiproliferative ef- ical and clinical studies; bestatin could inhibit lymph node fects of actinonin on human and murine leukemia and lym- metastasis of P388 leukemia in mice (10) and was used in phoma cells. Actinonin inhibited growth of NB4 and HL6O clinical trials in malignant skin tumors (1 1), in head and neck human cell lines and AKR mouse leukemia cells in vitro with cancer (12), in esophageal cancer (13), and in gynecologic an IC50 of about 2-S g/ml. The inhibitory effect on CD13- tumors (14). High doses of bestatin resulted in the significant positive cells was not blocked by pretreatment with the inhibition of preexisting experimental and spontaneous metas- anti-CD13/APN monoclonal antibody F23, which binds with tasis in mice (15).
  • SCOMET List 2013

    SCOMET List 2013

    (Annexure to Notification No. 37(RE-2012)/2009-2014 Dated 14.03.2013) Special Chemicals, Organisms, Materials, Equipment and Technologies (SCOMET) export of which is regulated Export of Special Chemicals, Organisms, Materials, Equipment and Technologies (SCOMET) listed below shall be permitted only against an export licence issued in this behalf unless export is prohibited or is permitted without licence subject to fulfillment of conditions, if any, as indicated under/against any specific category or item. Provisions of Chapter IV A of the FT(D&R) Act,1992 as amended in 2010 shall apply to the goods, services and technologies specified in the list below. Supply of SCOMET Items from DTA to SEZ No export permission is required for supply of SCOMET items from DTA to SEZ. However, all supplies of SCOMET items from DTA to SEZ will be reported to the Development Commissioner of the respective SEZ by the supplier in the prescribed proforma (Annexure 1) within one (1) week of the supplies getting effected. An annual report of such supplies from DTA to SEZ shall be sent to SCOMET Cell, DGFT (Hqrs), Department of Commerce, Udyog Bhawan, Maulana Azad Road, New Delhi-110011, by the Development Commissioner (DC), SEZ in the prescribed proforma (Annexure 2) . Report by the DC, SEZ to be filed by 15th May of every financial year for the supplies effected during the preceding financial year. Export of SCOMET Items from SEZ to outside the country Export permission is required if the SCOMET items are to be physically exported outside the country from SEZ i.e.
  • Beverage Preparation Capsule for Delivery of a Solubilisate

    Beverage Preparation Capsule for Delivery of a Solubilisate

    (19) TZZ¥ _¥_T (11) EP 3 216 443 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 13.09.2017 Bulletin 2017/37 A61K 9/00 (2006.01) A47J 31/40 (2006.01) A47J 31/00 (2006.01) B65D 85/804 (2006.01) (21) Application number: 16000586.4 (22) Date of filing: 10.03.2016 (84) Designated Contracting States: (71) Applicant: Athenion AG AL AT BE BG CH CY CZ DE DK EE ES FI FR GB 6304 Zug (CH) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR (72) Inventors: Designated Extension States: • Brysch, Ekkehard BA ME 26316 Varel (DE) Designated Validation States: • Brysch, Wolfgang MA MD 13505 Berlin (DE) • von Wegerer, Jörg 13597 Berlin (DE) (54) BEVERAGE PREPARATION CAPSULE FOR DELIVERY OF A SOLUBILISATE (57) The present invention relates to a beverage pensing system. Poorly water-soluble dietary supple- preparation capsule for the delivery of a solubilisate, a ments or pharmaceutical active agents can be delivered beverage dispensing system configured for the use of in this new dosage form in order to increase the bioavail- such a beverage preparation capsule and a method for ability of these substances. preparing a beverage by means of such a beverage dis- EP 3 216 443 A1 Printed by Jouve, 75001 PARIS (FR) 1 EP 3 216 443 A1 2 Description bilayer of the cell membrane. Often the same or struc- turally related components are used for liposomes as [0001] The present invention relates to a beverage those known from the cell membrane, therefore display- preparation capsule for the delivery of a solubilisate, a ing similar physicochemical properties.
  • United States Patent 19 11) 4,045,383 Koff 45) Aug

    United States Patent 19 11) 4,045,383 Koff 45) Aug

    United States Patent 19 11) 4,045,383 Koff 45) Aug. 30, 1977 (54) STABLE EMULSIONS AND IMPROVED (56) References Cited TEMPERATURE MONITORING FILMS FOREIGN PATENT DOCUMENTS PREPARED THEREFROM 1,138,590 1/1969 United Kingdom (75) Inventor: Arnold Koff, West Orange, N.J. OTHER PUBLICATIONS (73) Assignee: Hoffmann-La Roche Inc., Nutley, Chem. Abstract 48:225 h. N.J. Chem. Abstract 64:17,361 g. 21 Appl. No.: 651,010 Primary Examiner-Theodore Morris Attorney, Agent, or Firm-Samuel L. Welt; Bernard S. 22) Filed: Jan. 21, 1976 Leon; William M. Farley 57 ABSTRACT Related U.S. Application Data Improved temperature monitoring films formed from (63) Continuation of Ser. No. 221,408, Jan. 27, 1972, stable emulsions containing compounds capable of ex abandoned, which is a continuation-in-part of Ser. No. isting in the cholesteric liquid crystalline phase which 885,353, Dec. 15, 1969, abandoned. are protected and stabilized against aging, and the atmo 51 Int. C.’................................................ C09K 3/34 sphere by the inclusion of an antioxidant are provided. (52) U.S. C. ................................... 260/8; 23/230 LC; The thus-formed film materials are used in thermogra 106/135; 252/299 phy and/or thermometry. 58) Field of Search ........................ 106/135; 252/299; 260/8; 428/1; 23/230 LC 3 Claims, No Drawings 4,045,383 1. 2 viewed, has an apparent color which is a complement of STABLE EMULSONS AND MPROVED the color of the light transmitted through the film. TEMPERATURE MONTORING FILMS The terms "light” and "color" as used herein have a PREPARED THEREFROM broad connotation of referring to electromagnetic radi ation generally, rather than to solely visible radiation.
  • Generate Metabolic Map Poster

    Generate Metabolic Map Poster

    Authors: Pallavi Subhraveti Ron Caspi Peter Midford Peter D Karp An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Ingrid Keseler Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_003855395Cyc: Shewanella livingstonensis LMG 19866 Cellular Overview Connections between pathways are omitted for legibility.